Cocrystal Pharma, Inc.
Ticker: 1412486
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2020 | Q2 FY2020 |
|---|---|---|---|
| INCOME | |||
| Revenue | 0.23-53.1% | 0.49-10.9% | 0.55 |
| Total Income | 0.23-53.1% | 0.49-10.9% | 0.55 |
| EXPENSES | |||
| Expenditure | 2.58-19.4% | 3.20-20.0% | 4.00 |
| Tax | 0.00 | — | — |
| PROFIT | |||
| Net Profit | -2.30+13.9% | -2.67+23.7% | -3.50 |
| KEY METRICS | |||
| OPM % | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% |
| EPS | -0.17 | — | — |
Corporate Events
Board MeetingCOCP
202614Jul
Board Meeting
Voting results from the 2026 Annual Meeting of Stockholders …
SEC Filing ↗ Board MeetingCOCP
20263Jun
Board Meeting
James Sapirstein appointed as Chief Executive Officer and pl…
SEC Filing ↗